Vernal Keratoconjunctivitis

DBCOND0036467Eye DiseaseImmune System Diseases

Vernal Keratoconjunctivitis is the indication for 5 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as
Keratoconjunctivitis, Vernal · Seasonal conjunctivitis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0005020ICD-10H10.44SNOMED CT155536000MedDRA10001726UMLSC0009773

What you can answer from here — as of October 23, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
15Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Vernal Keratoconjunctivitis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In